Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - HeartWare International, Inc.c96743exv99w1.htm
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 22, 2010

HEARTWARE INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)

         
Delaware   001-34256   26-3636023
(State or other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)
     
205 Newbury Street, Suite 101
Framingham, MA
  01701
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: 508.739.0950

 
 
(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

1


 

Item 7.01 Regulation FD Disclosure

On Febrauary 22, 2010, HeartWare International, Inc. (the “Company”) issued a press release announcing early conclusion of its U.S. bridge-to-transplant trial. A copy of the release is furnished with this report as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits

     
Exhibit  No.   Description 
 
   
99.1 
  Press Release issued by HeartWare International, Inc. dated February 22, 2010.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    HeartWare International, Inc.

Date: February 22, 2010
  By:   /s/ David McIntyre
 
       
 
      Name: David McIntyre
 
      Title: Chief Financial Officer and Chief Operating Officer

 

2